What is the Jeonjin Biofarm Co., Ltd. stock price forecast?

Jeonjin Biofarm Co., Ltd. is currently trading at ₩1,775. View real-time AI analysis on Alpha Lenz.

What is Jeonjin Biofarm Co., Ltd. insider trading activity?

View the latest insider trading data for Jeonjin Biofarm Co., Ltd. on Alpha Lenz.

What is Jeonjin Biofarm Co., Ltd.'s P/E ratio?

Jeonjin Biofarm Co., Ltd.'s P/E ratio is -82.1.

Jeonjin Biofarm Co., Ltd.

KRX · 110020

₩1,775-32(-1.77%)Market closed

Ask about Jeonjin Biofarm Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Jeonjin Biofarm Co., Ltd. trades at a P/E of -82.1 (undervalued) with modest ROE of -1.1%. 3Y revenue CAGR of 20.7% highlights clear growth momentum.”

Ask for details →

Company Overview

Jeonjin Biofarm Co., Ltd. is a prominent player in the pharmaceutical and biotechnology sectors, specializing in the research, development, and production of herbal and natural ingredient-based medications. The company is dedicated to improving public health by focusing on the therapeutic potential of plant-derived substances. Jeonjin Biofarm’s portfolio extends across a diverse range of therapeutic areas, including anti-inflammatory, liver health, and immune system support, catering to both domestic and international markets. Headquartered in South Korea, the company emphasizes rigorous scientific research and development processes to ensure the efficacy and safety of its products. In the financial markets, Jeonjin Biofarm Co., Ltd. holds a strategic position as an innovative entity within the bio-pharmaceutical industry, contributing to the advancement of alternative therapeutic solutions. Its focus on traditional medicine combined with modern pharmaceutical applications positions it uniquely in the sector, underlining its commitment to sustainable and holistic healthcare solutions.

CEO이태훈

Websitehttps://www.jjbio.co.kr

SectorBasic Materials

IndustrySpecialty Chemicals

Company Statistics

FY 2025

Profile

₩16,079,302,550Market Cap

₩13,694,344,910Revenue

9.06MShares Out

0Employees

Margins

27.60%Gross

2.50%EBITDA

-2.50%Operating

-1.43%Pre-Tax

-1.43%Net

Valuation

-82.12P/E

0.92P/B

1.17EV/Sales

28.25EV/EBITDA

-52.28P/FCF

Growth (CAGR)

20.67%Rev 3Yr

28.78%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-1.05%ROA

-1.12%ROE

-1.05%ROIC

Financial Health

₩6,412,210,360Cash & Cash Equivalents

₩-5,311,304,620Net Debt

6.32%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Jeonjin Biofarm Co., Ltd. trades at a P/E of -82.1 (undervalued) with modest ROE of -1.1%. 3Y revenue CAGR of 20.7% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Jeonjin Biofarm Co., Ltd. (ticker: 110020) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). Market cap is $16.1B.

The current price is ₩1,775 with a P/E ratio of -82.12x and P/B of 0.92x.

ROE is -1.12% and operating margin is -2.50%. Annual revenue is $13.7B.